Correlation Between Cisco Systems and Defence Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cisco Systems and Defence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cisco Systems and Defence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cisco Systems and Defence Therapeutics, you can compare the effects of market volatilities on Cisco Systems and Defence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cisco Systems with a short position of Defence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cisco Systems and Defence Therapeutics.

Diversification Opportunities for Cisco Systems and Defence Therapeutics

0.64

Correlation Coefficient

Cisco Systems  Defence Therapeutics

Poor diversification

The 3 months correlation between Cisco and Defence is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Cisco Systems and Defence Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Defence Therapeutics and Cisco Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cisco Systems are associated (or correlated) with Defence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Defence Therapeutics has no effect on the direction of Cisco Systems i.e., Cisco Systems and Defence Therapeutics go up and down completely randomly.

Pair Corralation between Cisco Systems and Defence Therapeutics

Given the investment horizon of 90 days Cisco Systems is expected to generate 30.02 times less return on investment than Defence Therapeutics. But when comparing it to its historical volatility, Cisco Systems is 7.56 times less risky than Defence Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Defence Therapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  39.00  in Defence Therapeutics on December 28, 2024 and sell it today you would earn a total of  61.00  from holding Defence Therapeutics or generate 156.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.39%
Values	Daily Returns

Cisco Systems  vs.  Defence Therapeutics

Cisco Systems

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cisco Systems are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental indicators, Cisco Systems is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Defence Therapeutics

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Defence Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Defence Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cisco Systems and Defence Therapeutics

The main advantage of trading using opposite Cisco Systems and Defence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cisco Systems position performs unexpectedly, Defence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Defence Therapeutics will offset losses from the drop in Defence Therapeutics' long position.

The idea behind Cisco Systems and Defence Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.